Reviewing my career as a hematologist-oncologist and a quality control specialist in clinical trials
After a long-term hospitalization following a ski accident in college, I decided to choose a specialty in hematology and oncology. In graduate school, after learning the basics of biostatistics and the methodology of clinical trials, I had the opportunity to go through a series of clinical trial tasks, from launching to writing a clinical study report, which led to the study drug approval. This has greatly motivated me to be actively involved in this field. At the Dana-Farber Cancer Institute, I studied outcomes research under a supervisor, and at a time of difficulty, my good role model, Dr. Stephanie Lee, had urged me, saying, "That which does not kill you makes you stronger." Subsequently, I devoted myself to the establishment of a data center for a Japanese pediatric leukemia/lymphoma study group, currently a subcommittee of the Japan Children's Cancer Group, and to develop an academic research organization for conducting ICH-GCP-compliant international clinical trials, including the originally developed EDC system. I was struggling in balancing work and parenting. Fortunately, I was supported by my encounters with respectable people.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:63 |
|---|---|
| Enthalten in: |
Rinsho ketsueki] The Japanese journal of clinical hematology - 63(2022), 8 vom: 22., Seite 928-933 |
| Sprache: |
Japanisch |
|---|
| Beteiligte Personen: |
Saito, Akiko [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Female physician |
|---|
| Anmerkungen: |
Date Completed 07.09.2022 Date Revised 07.09.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.11406/rinketsu.63.928 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM345760816 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM345760816 | ||
| 003 | DE-627 | ||
| 005 | 20231226025816.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||jpn c | ||
| 024 | 7 | |a 10.11406/rinketsu.63.928 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1152.xml |
| 035 | |a (DE-627)NLM345760816 | ||
| 035 | |a (NLM)36058864 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a jpn | ||
| 100 | 1 | |a Saito, Akiko |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Reviewing my career as a hematologist-oncologist and a quality control specialist in clinical trials |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.09.2022 | ||
| 500 | |a Date Revised 07.09.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a After a long-term hospitalization following a ski accident in college, I decided to choose a specialty in hematology and oncology. In graduate school, after learning the basics of biostatistics and the methodology of clinical trials, I had the opportunity to go through a series of clinical trial tasks, from launching to writing a clinical study report, which led to the study drug approval. This has greatly motivated me to be actively involved in this field. At the Dana-Farber Cancer Institute, I studied outcomes research under a supervisor, and at a time of difficulty, my good role model, Dr. Stephanie Lee, had urged me, saying, "That which does not kill you makes you stronger." Subsequently, I devoted myself to the establishment of a data center for a Japanese pediatric leukemia/lymphoma study group, currently a subcommittee of the Japan Children's Cancer Group, and to develop an academic research organization for conducting ICH-GCP-compliant international clinical trials, including the originally developed EDC system. I was struggling in balancing work and parenting. Fortunately, I was supported by my encounters with respectable people | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Female physician | |
| 650 | 4 | |a Quality control specialist in clinical trials | |
| 650 | 4 | |a Role model | |
| 773 | 0 | 8 | |i Enthalten in |t Rinsho ketsueki] The Japanese journal of clinical hematology |d 1972 |g 63(2022), 8 vom: 22., Seite 928-933 |w (DE-627)NLM000222178 |x 0485-1439 |7 nnns |
| 773 | 1 | 8 | |g volume:63 |g year:2022 |g number:8 |g day:22 |g pages:928-933 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.11406/rinketsu.63.928 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 63 |j 2022 |e 8 |b 22 |h 928-933 | ||